13Feb
Ahead of the pack: US M&A 2019: Biotech boosts US healthcare M&A in 2019
The healthcare sector (incorporating pharma, medical and biotech) has seen M&A valued at US$256.5 billion across 645 deals in 2019. This is a decrease of 9 percent by volume, but an increase of 121 percent by value....
By:
White & Case LLP
Related
Welcome to your weekly update from the Allen & Overy Pensions team, bringing you up to speed on the ...
Read More >
On October 26, 2020, we provided an overview of the key features of Bill 37, Builders' Lien (Prompt ...
Read More >
In its first significant decision applying the Supreme Court’s holding in Epic Systems v. NLRB, 584...
Read More >
On December 1, 2020, the Orange County Board of County Commissioners (BCC) voted unanimously to adop...
Read More >
Oregon is the latest state to enact a paid family and medical leave law. The law, which will cover a...
Read More >
Distressed M&A may offer a silver lining for both buyers and sellers ? if you look for that break in...
Read More >